Профилактика и работа в условиях пандемии COVID-19 в учреждениях долговременного ухода в Европейском регионе ВОЗ
В настоящем техническом руководстве определено ...десять задач для лиц, принимающих решения,
разработчиков политики и национальных или региональных органов здравоохранения, стремящихся
обеспечить профилактику и работу в условиях пандемии COVID в учреждениях долговременного ухода.
more
Severe acute respiratory infections treatment centre: practical manual to set up and manage a SARI treatment centre and a SARI screening facility in health care facilities
In this video, you will be provided with an overview of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2). This lecture will cover the general characteristics of coronaviruses and the origin of the coronavirus disease 2019 (COVID-19).
To gauge the need for supplies/equipment and health work force requirements during the COVID-19 pandemic, WHO has developed a suite of complimentary surge calculators -- one for supplies and two for health workforce. All tools use the same base epidemiologic assumptions and classify health workforc...e using standardized International Labor Organization International Standard Classification of Occupations codes, but their outputs are intentionally different due to their primary focus
more
Adults and adolescents 12+ years. Asthma medication options: Adjust treatment up and down for individual patient needs
COVID-19 / SARS-CoV-2 (2019-nCoV)
SARS-CoV-2: a respiratory coronavirus that emerged in late 2019 from live animal markets in Wuhan, China. Bats are the reservoir species.
With the growing prevalence of type 2 diabetes, particularly in emerging countries, its management in the context of available resources should be considered. International guidelines, while comprehensive and scientifically valid, may not be appropriate for regions such as Asia, Latin America or Afr...ica, where epidemiology, patient phenotypes, cultural conditions and socioeconomic status are different from America and Europe. Although glycaemic control and reduction of micro- and macrovascular outcomes remain essential aspects of treatment, access and cost are major limiting factors; therefore, a pragmatic approach is required in restricted-resource settings. Newer agents, such as sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in particular, are relatively expensive, with limited availability despite potentially being valuable for patients with insulin resistance and cardiovascular complications. This review makes a case for the role of more accessible second-line treatments with long-established efficacy and affordability, such as sulfonylureas, in the management of type 2 diabetes, particularly in developing or restricted-resource countries.
more
Arabic Version of COVID-19 guidance for educational settings
Government measures in response to the outbreak have included severe restrictions on movement and physical distancing, which will inevitably impact the way we engage communities. This document provides key messages and practical tips for such community engagement.
Cette affiche est destinée au grand public et montre comment prévenir le COVID-19. Il fournit également un numéro de téléphone pour plus d'informations
The aim of the register is to support rapid evidence synthesis by all systematic review producers, including Cochrane's work on Rapid Reviews in response to COVID-19. The register helps systematic reviewers prioritize topics, identify available evidence, and produce urgently needed reviews for front...-line health professionals, public health policymakers, and research teams developing new therapeutic, diagnostic, and preventive interventions for COVID-19.
The new COVID-19 Study Register will be continually updated with human studies on COVID-19. More background information about the register can be found here: https://community.cochrane.org/about-covid-19-study-register
more
Overview on Covid-19 and emergency medicine
Globally, the cancer burden is rising, exerting significant strain on
populations and health systems at all levels of income. There are
concerted efforts towards enhancing access to comprehensive
cancer prevention and control initiatives.